• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.39% Nasdaq Up1.53%

    Ampio Pharmaceuticals, Inc. (AMPE)

    -NYSE MKT
    3.55 Down 0.02(0.62%) 10:50AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 50   50   19  
    Cost of Revenue -   -   -  
    Gross Profit 50   50   19  
    Operating Expenses
    Research Development18,289  7,494  6,648  
    Selling General and Administrative5,785  4,377  4,504  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (24,024) (11,821) (11,134)
    Income from Continuing Operations
    Total Other Income/Expenses Net(505)228  (7,134)
    Earnings Before Interest And Taxes(24,528)(11,593)(18,268)
    Interest Expense -   -  8  
    Income Before Tax(24,528)(11,593)(18,277)
    Income Tax Expense -   -  83  
    Minority Interest520   -   -  
    Net Income From Continuing Ops(24,009)(11,593)(18,359)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (24,009) (11,593) (18,359)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (24,009) (11,593) (18,359)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.